This article is a correction to:
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
Máté Krausz1,2,3,4†
Noriko Mitsuiki2†Valeria Falcone5Johanna Komp6Sara Posadas-Cantera1,2,6Hanns-Martin Lorenz7Jiri Litzman8Daniel Wolff9Maria Kanariou10Anita Heinkele11Carsten Speckmann1,2,12Georg Häcker6Hartmut Hengel5Laura Gámez-Díaz1,2Bodo Grimbacher1,2,3,13,14,15*- 1Institute for Immunodeficiency, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 2Center for Chronic Immunodeficiency (CCI), Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 3Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 4Faculty of Biology, University of Freiburg, Freiburg, Germany
- 5Institute of Virology, University Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 6Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 7Division of Rheumatology, Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
- 8Department of Clinical Immunology and Allergology, St. Anne’s University Hospital in Brno and Medical Faculty, Masaryk University, Brno, Czechia
- 9Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
- 10Department of Immunology and Histocompatibility, Centre for Primary Immunodeficiencies, “Aghia Sophia” Children’s Hospital, Athens, Greece
- 11Center for Pediatric Rheumatology, Olgahospital, Stuttgart, Germany
- 12Department of Pediatric Hematology and Oncology, Center for Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 13DZIF – German Center for Infection Research, Satellite Center Freiburg, Freiburg, Germany
- 14CIBSS – Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany
- 15RESIST – Cluster of Excellence 2155 to Hannover Medical School, Satellite Center Freiburg, Freiburg, Germany
A Corrigendum on
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
By Krausz M, Mitsuiki N, Falcone V, Komp J, Posadas-Cantera S, Lorenz H-M, Litzman J, Wolff D, Kanariou M, Heinkele A, Speckmann C, Häcker G, Hengel H, Gámez-Díaz L and Grimbacher B (2022) Front. Immunol. 13:1011646. doi: 10.3389/fimmu.2022.1011646
In the published article, there was an error in the Funding statement. The following funding information is missing: “We acknowledge support by the Open Access Publication Fund of the University of Freiburg.” The correct Funding statement appears below.
Funding
This work was supported by the Deutsche Forsch-ungsgemeinschaft (DFG) IMPATH SFB1160/2_B5. BG receives support by the Deutsche Forschungsgemeinschaft (DFG) SFB1160/2_B5, under Germany’s Excellence Strategy (CIBSS – EXC-2189 – Project ID 390939984, and RESIST – EXC 2155 – Project ID 390874280); by the E-rare program of the EU, managed by the DFG, grant code GR1617/14-1/iPAD; and by the German Federal Ministry of Education and Research (BMBF) through a grant to the German Auto-Immunity Network (GAIN), grant code 01GM1910A. HH is funded by the Deutsche Forschungsgemeinschaft (DFG) through HE2526/9-1. MK is supported by the Deutsche Forschungsgemeinschaft (DFG) SFB1160_2 as clinician scientist associated to IMM-PACT-Program, Faculty of Medicine, University of Freiburg, Freiburg, Germany. We acknowledge support by the Open Access Publication Fund of the University of Freiburg.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cytotoxic T-lymphocyte antigen 4 (CTLA-4), immunodeficencies, immune dysregulation, inborn errors of immunity (IEI), disease modifiers
Citation: Krausz M, Mitsuiki N, Falcone V, Komp J, Posadas-Cantera S, Lorenz H-M, Litzman J, Wolff D, Kanariou M, Heinkele A, Speckmann C, Häcker G, Hengel H, Gámez-Díaz L and Grimbacher B (2023) Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency? Front. Immunol. 14:1226814. doi: 10.3389/fimmu.2023.1226814
Received: 22 May 2023; Accepted: 23 May 2023;
Published: 02 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Krausz, Mitsuiki, Falcone, Komp, Posadas-Cantera, Lorenz, Litzman, Wolff, Kanariou, Heinkele, Speckmann, Häcker, Hengel, Gámez-Díaz and Grimbacher. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bodo Grimbacher, bodo.grimbacher@uniklinik-freiburg.de
†These authors have contributed equally to this work